Henry Liberman

Emory University

Papers

7

Total Citations

262

H-Index

7

About

Henry Liberman is a leading cardiac surgeon whose research focuses on advancing minimally invasive coronary revascularization, particularly through robotic-assisted and hybrid surgical techniques. His work has significantly shaped modern approaches to coronary artery bypass grafting (CABG), demonstrating that robotic-assisted surgery can achieve excellent early clinical and angiographic outcomes, as shown in his most-cited paper (103 citations). Liberman pioneered the evaluation of hybrid coronary revascularization—combining minimally invasive bypass with percutaneous stenting—proving its cost-effectiveness and favorable reimbursement profiles (31 citations). He also established the accuracy of transit time flow measurement as a reliable intraoperative tool for predicting graft patency, challenging the reliance on postoperative angiography (29 citations). His studies on risk factors for conversion to sternotomy (19 citations) and the impact of clopidogrel on postoperative bleeding (12 citations) have provided critical safety insights, helping surgeons optimize patient selection and perioperative management. With over 260 total citations across his key works, Liberman’s contributions have not only refined surgical protocols but also expanded access to less invasive cardiac procedures, making him a pivotal figure in the evolution of coronary artery disease treatment.

Research Focus

Key Achievements

7
H-Index
7
Papers
262
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery
103 citations · 2013
📈 Most Prolific Year: 2013 (3 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Emory University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago